MIRA INFORM REPORT

 

 

Report Date :

16.03.2007

 

IDENTIFICATION DETAILS

 

Name :

INDOVAX PRIVATE LIMITED

 

 

Registered Office :

8th Floors,Eros Apartments, 56 Nehru Place, New Delhi;110019

 

 

Country :

India

 

 

Financials (as on) :

31.03.2006

 

 

Date of Incorporation :

23.06.1986

 

 

Com. Reg. No.:

024582

 

 

CIN No.:

[Company Identification No.]

U74899DL1986PTC024582

 

 

Legal Form :

Private Limited Liability Company.

 

 

Line of Business :

The company is engaged in manufacturing and trading of Poultry Vaccines and Animal (Poultry) Health Products.

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 800000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject is a well-established and reputed company having satisfactory track. Directors are reported as experienced and respectable businessmen. Trade relations are reported as fair. Business is active. Payment are usually correct and as per commitments.

 

The company can be considered normal for business dealings at usual trade terms and conditions.

 

 

LOCATIONS

 

Registered Office :

8th floors Apartments, 56 nehru place New Delhi:110019

Tel. No.:

91-11-26462854

E-Mail :

India585@nd.vsnl.net.in

Web site:

http://www.indovax.com

Area :

800 Sq.ft

Location :

leased

 

 

Corporate Office :

Corporate Heights, Soc-24, Sector-14, Gurgaon, Haryana-122001 (India)

Tel. No.:

91-124-2315044/ 45 / 46

Fax No.:

91-124-2314680

E-Mail :

mail@indovax.com

 

 

FACTORY / WAREHOUSE:

Village Siswala, P.O. Rawalwas Khurd, Hissar – 125 001, Haryana

Area :

5,000 sq.mtr

Location :

owned

 

DIRECTORS

 

Name :

Mr. Vinod Somnath Kapur

Designation :

Chairman Cum Managing Director

Address :

Village Khandsa Delhi Jaipur Road, Gurgon:122001 Haryana

Date of Birth/Age :

20.07.1934

Date of Appointment :

23.06.1986

 

 

Name :

Mr. Shashi Kapur

Designation :

Managing Director

Address :

Village Khandsa Delhi Jaipur Road, Gurgon:122001 Haryana

Date of Birth/Age :

01.12.1947

Date of Appointment :

23.06.1986

 

 

Name :

Dr. Srirangachar Belu KJeshavamurthy

Designation :

Director

Address :

59, Lower Palace Orchards Bangalore:560003, Karnataka

Date of Birth/Age :

09.10.1928

Date of Appointment :

30.12.1988

 

 

Name :

Mr. Sudhir Varma

Designation :

Director

Address :

10, Sector-18, Chandigarh

Date of Birth/Age :

19.08.1980

Date of Appointment :

24.10.1991

 

 

Name :

Mr. Rahul Kapur

Designation :

Director

Address :

J-6/6, DLF Phase-2, DLF Qutab Enclave, Gurgaon, Haryana

 

 

 

 

 

MAJOR SHAREHOLDERS

 

Names of Shareholders

 

No. of Shares

Vinod Somnath Kapur

 

304822

Shashi Kapur

 

104108

Janak Mohini Kapur

 

7500

 

Equity Share Breakup:

Category

Percentage

Directors or relatives of Directors

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

The company is engaged in manufacturing and trading of Poultry Vaccines and Animal (Poultry) Health Products.

 

 

Products :

New Castle Disease, Infectious Bursal Disease, Marek’s Disease, Infectious Bronchitis, Flow Pox, Fowl Cholera, E D S’76, Hydropericardium Syndrome, Infectious Coryza, Combinations

 

 

Imports :

 

Countries :

Italy, Belgium and USA.

 

 

Terms :

 

Selling :

cash, credit (30 to 60 days) and others terms.

 

 

Purchasing :

L/C, Credit (30 to 60 days) and others terms.

 

 

GENERAL INFORMATION

 

Customers :

Wholesalers and poultry farms.

 

 

No. of Employees :

65

 

 

Bankers :

UTI Bank Ltd. Sco-13, Sector-14. Gurgaon-122001

Indian Bank, Nehru Place, New Delhi – 110 019

Indian Bank, Hissar, Haryana

Canara Bank, East Patel Road, New Delhi

Syndicate Bank, East Patel Road, New Delhi

 

 

 

Facilities :

--

 

 

 

Banking Relations :

Satisfactory

 

 

Auditors :

 

Name :

D.C.Jain and Associates

Chartered Accountant

Address :

A-14/3, Jamna Bhawan Asaf Ali Road, New Delhi:110002, Delhi

 

 

Associates/Subsidiaries :

Keggfarms Private Limited, India

 

 

CAPITAL STRUCTURE

 

Authorised Capital :

No. of Shares

Type

Value

Amount

500000

Equity Shares

Rs.100/-Each

Rs.50.000 Millions

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

416430

Equity Shares

Rs.100/-Each

Rs.41.643 Millions

 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

 

31.03.2006

31.03.2005

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

 

41.643

41.643

2] Share Application Money

 

0.000

0.000

3] Reserves & Surplus

 

159.170

151.489

4] (Accumulated Losses)

 

0.000

0.000

NETWORTH

 

200.813

193.132

LOAN FUNDS

 

 

 

1] Secured Loans

 

16.614

22.235

2] Unsecured Loans

 

5.388

11.666

TOTAL BORROWING

 

22.002

33.901

DEFERRED TAX LIABILITIES

 

17.094

16.777

 

 

 

 

TOTAL

 

239.909

243.810

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

 

105.470

111.050

Capital work-in-progress

 

2.194

0.083

 

 

 

 

INVESTMENT

 

0.146

0.145

DEFERREX TAX ASSETS

 

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

 

78.010

58.311

 

Sundry Debtors

 

76.292

84.068

 

Cash & Bank Balances

 

12.758

26.055

 

Other Current Assets

 

0.000

0.000

 

Loans & Advances

 

3.404

3.950

Total Current Assets

 

170.464

172.384

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Current Liabilities

 

24.408

25.242

 

Provisions

 

13.957

14.610

Total Current Liabilities

 

38.365

39.852

Net Current Assets

 

132.099

132.532

 

 

 

 

MISCELLANEOUS EXPENSES

 

 

 

 

 

 

 

TOTAL

 

239.909

243.810

 


 

KEY RATIOS

 

PARTICULARS

 

 

 

31.03.2006

31.03.2005

Debt Equity Ratio

(Total Liability/Networth)

 

 

0.19

0.20

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

 

4.44

4.32

 

 

LOCAL AGENCY FURTHER INFORMATION

 

 

Name of the company

INDOVAX PRIVATE LIMITED

Presented By

Mr. Shashi Kapur Managing Director

1) Date and description of instrument creating the change

Deed of Hypothecation of Current Assets. Book Debts, Machinery and other Movable fixed assets dated 02.09.2004 and mortage by deposit of title deeds was created by the company in favour of UTI Bank Ltd. In respect of immovable properties of the company situated at Village Siswala, P.O. Rawalwas Khurd. Hisar, Haryana (No instrument was executed for mortage f immovable properties of the Company)- Registered on 13.09.2004

2) Amount secured by the charge/amount owing on the securities of charge

Rs.42.500 Millions

3) Short particular of the property charged. If the property acquired is subject to charge, date of the acquired of the property should be given

As per Deed of hypothecation of Current Assets dated 02.09.2004

 

As per Deed of Hypothecation of Book Debts dated 02.09.2004

 

As per Deed of Hypothecation of Machinery and other movable fixed assets: dated 02.09.2004

 

As per Schedule  A and B attached (with respect t mortgage of immovable properties of the company)

4) Gist of the terms and conditions and extent and operation of the charge.

Facilities within the overall limit:

Cash Credit:

Rs.40.000 Millions

Sub Limit-PC/FBP/FBD

Rs.(3.000) Millions

Letter of Credit(Import/ Inland)

Rs.2.500 Millions

Totla:

Rs.42.500 Millions

 

Margin :

Cash Credit:

Raw Material/Finished Goods

25%

Book Debts(not older than 90 days)

35%

WIP/ Stores and Spares

30%

EPC/FBD:

 

Margin on Stocks

25%

Margin on Bills

25%

Letter of Credit

25%

 

Interest:

Cash Credit: BPLR less 0.50% i.e; 11.50 % p.a payable monthly

 

EPC/FBD:

 

Preshipment:

Upto 180 days :                                 9.50%p.a

180 days -360 days                          14.00% p.a

 

Postshipments:

Upto 90days                                      9.5% p.a

90 days-180 day                             12.50% p.a

 

L/C –As per Bank’s /RBI Guidelines

 

Repayment: On demand

5) Name and Address and description of the person entitled to the charge.

UTI Bank Ltd. Sco-13, Sector-14. Gurgaon-122001

6) Date  and brief description of instrument modifying the charge

Deed fo Hypothecation of Current Assets dt: 10.02.2006

 

Deed of hypothecation of Machinery and other movable fixed assets dt.10.02.2006

 

Term Loan Agreement dt:10.02.2006

7) Particulars of modifications specifying the terms and conditions or the extent of operations of the charge in which modification is made and the details of the modification.

Facilities within the overall limit of Rs.62.500 Millions have been modified as under:

 

Cash Credit

Rs.40.000 Millions

Export Bills Discounting Facilities

(Sub-limits to cash Credit Limit)

Rs. (3.000) Millions

Letter of Credit

(Inland and foreign LC’s

Rs.2.500 Millions

Term loan:

Rs.20.000 Millions

Total:

Rs.62.500  Millions

 

Pricing :

Cash Credit: PLR Less 2% effective 10% p.a payable monthly

 

Exporrt Credit Facilities – PLR Less 3.5% effective 8.50%

 

Letter of Credit- As per Bank’s/ FEDAI guidelines

 

Term Loan- PLR Less 2% effective 10% p.a payable monthly

 

Margin:

Cash Credit:

Inventory:25%

 

Export Credit Facilities:

EPC -25% on stocks

EBD-Nil

 

Letter of Credit-25%

 

Repayment:

Cash Credit/ Ex[port Credit Facilities- on Demand

 

Term Loan-84 equated monthly installment of Rs.0.332 Millions each from the month of disbursement.

 

As Per Web Site:

 

THE COMPANY is engaged in the production of quality poultry biologicals since 1991.

Nowhere in the world is fighting poultry diseases easy. In India it is even more difficult because of the complexities involved.

 

Severe agro-climatic conditions with temperatures varying from 0oC to 46oC; humidity varying from 0% to 100%; even housing varying from crudely put together sheds to modern cage system and environment controlled housing, resulting in a hugely complex scenario where bacteria and viruses thrive. This is why the country presents one of the toughest bio-security challenges anywhere in the world.

In the face of such adversity, poultry farmers in India have still managed to reach productivity levels that could be compared with the best in the world.

 

All this has been possible because the Indian poultry farmer has been able to not only improve his own efficiency, but also tackle the many poultry disease challenges that he has encountered.

 

When the dreaded Gumboro disease hit the Indian poultry farmer in early 90s and farmers were losing 10% to 90% chickens at their farm ... when no other product - Indian or International worked ... it was THE COMPANY products that were able to successfully control this dreaded disease.

 

Since then, THE COMPANY with its research focused at product development for Indian (tropical) conditions and a unique holistic approach to poultry disease challenges, as distinct from a product approach, has helped the Indian poultry farmer in overcoming the ever-increasing and challenging disease problems

.

THE COMPANY believes that there is much more to combating poultry diseases than just producing vaccines - relevant research, specific products and specially designed vaccination programmes. RESEARCH, QUALITY, INNOVATION, TECHNICAL SERVICES ...

 

... that is THE COMPANY for you.

 

 

 

Spread over 14 acres in a completely poultry-free zone, THE COMPANY has a most modern state-of-the-art facility designed to not only match, but exceed the global standards.

 

THE COMPANY products   that    consist  of  viral  vaccines, inactivated vaccines and bacterins are manufactured by using  SPF  eggs  and  the  best  quality  raw  material, sourced from renowned international suppliers.

 

 

 

 

All THE COMPANY products meet the highest quality standards.

 

 

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.42.74

UK Pound

1

Rs.84.90

Euro

1

Rs.57.79

 

 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

6

OPERATING SCALE

1~10

6

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

7

--PROFITABILIRY

1~10

5

--LIQUIDITY

1~10

6

--LEVERAGE

1~10

6

--RESERVES

1~10

6

--CREDIT LINES

1~10

6

--MARGINS

-5~5

 

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

54

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average/normal.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NR

In view of the lack of information, we have no basis upon which to recommend credit dealings

No Rating

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions